Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MyHealthChecked PLC ( (GB:MHC) ) has shared an announcement.
MyHealthChecked PLC reported a revenue of £0.5 million for the first half of 2025, a decrease from the previous year, but noted a 60% increase in its wellness portfolio. The company has strengthened its market position through strategic partnerships, including a significant collaboration with Boots for the supply of lateral flow self-tests and laboratory tests under Boots’ Own Brand label. This partnership, along with the integration with Patients Know Best to provide test results via the NHS App, is expected to enhance customer engagement and drive future growth. Despite a decline in COVID test sales, MyHealthChecked is optimistic about the long-term growth potential of its wellness products.
More about MyHealthChecked PLC
MyHealthChecked PLC is a UK-based healthcare company specializing in at-home healthcare and wellness tests. The company offers a range of rapid tests and sample collection kits for blood, urine, nasal, or mouth swabs, which are analyzed in partner laboratories. MyHealthChecked aims to make healthcare more accessible and affordable, focusing on the growing at-home testing market.
Average Trading Volume: 42,187
Technical Sentiment Signal: Sell
Current Market Cap: £5.44M
For an in-depth examination of MHC stock, go to TipRanks’ Overview page.